|
|
ANN ARBOR, Mich., Feb. 11, 2011 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded autologous cellular therapies for the treatment of severe, chronic cardiovascular diseases, today announced that company president and CEO Tim Mayleben will speak at the 13th Annual BIO CEO & Investor Conference in the Park South wing of the Waldorf-Astoria Hotel on February 15 from 10:00-10:25 AM ET.
BIO CEO & Investor Conference is the largest independent investor conference
Continue reading: Aastrom to Present at 2011 BIO CEO & Investor Conference
Acquisition of Palladian Partners Provides Altarum with Vital New Health Communications and Marketing Capabilities
ANN ARBOR, Mich. –Altarum Institute President and CEO Lincoln Smith announced today that Altarum has finalized its acquisition of Silver Spring, Maryland-based Palladian Partners, Inc., a health communications and services company. Palladian will become a for-profit, wholly owned subsidiary of Altarum and will continue to operate from its current headquarters in Silver Spring.
“In our client-funded and internally chartered work, we are meeting
Continue reading: Institute Acquires Silver Spring, Maryland-Based Communications Firm Palladian Partners, Inc.
ANN ARBOR, Mich.—University of Michigan President Mary Sue Coleman has approved the final report on implementation of the new smoke-free policy that goes into effect July 1.
Leaders of the effort say the final plan was crafted after more than a year of extensive input from many in the campus and surrounding community.
"At the outset, we said we wanted to hear from representatives of all members of our community—faculty, staff, students, area residents, smokers, nonsmokers and
Continue reading: University of Michigan Goes Smoke-Free July 1
Ann Arbor, MI (November 23, 2010) – Lawrence Power, M.D. of Ann Arbor has launched “Erie Tales: Prose Poetry from a Doctoring Life,” an online collection of short stories based largely upon his experiences from a 50-year medical career.
The new site, found at www.erietales.com, derives its title from the setting of Dr. Powers’ stories – homespun, sometimes nostalgic, yet always insightful – in the mythical town of Fort Anguish, Ohio, on the shore of Lake
Continue reading: Dr. Lawrence Power, with DesignHub’s Help, Launches “Erie Tales” Website
Company Continues Its Plans to Rapidly Move Into a Phase 3 Program in 2011
ANN ARBOR, Mich., Nov. 18, 2010 (GLOBE NEWSWIRE) — Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that an interim analysis of all 86 patients enrolled in the company’s Phase 2b RESTORE-CLI clinical trial shows that the study achieved both its primary safety endpoint and primary efficacy endpoint of
Continue reading: Aastrom Presents Positive Second Interim Analysis of Phase 2b RESTORE-CLI Clinical Trial
Ann Arbor, Mich. (November 16, 2010) — Targeted cancer therapies such as trastuzumab (Herceptin), gefitinib (Iressa) and erlotinib (Tarceva) could be used to treat a wider range of cancers than previously thought, according to new research presented today (Wednesday) at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin.
Scientists in the USA have studied 20 genes that are targeted by existing therapies and found that there are significant changes to these
Continue reading: Tumor Analysis Reveals New Opportunities for Existing Cancer Drugs
|
|
Loading ...